Gisela B. Meyer

Porto Alegre, RS, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Journal: Lancet (London, England)

Published: April 22, 2026

Infectious Diseases and Pulmonary Arterial Hypertension: A Review.

Infectious Diseases and Pulmonary Arterial Hypertension: A Review.

Journal: Heart, lung & circulation

Published: November 24, 2025

Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.

Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.

Journal: The New England journal of medicine

Published: September 30, 2025

Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.

Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.

Journal: Pulmonary circulation

Published: January 20, 2025

Pathway to care, treatment and disease burden of pulmonary arterial hypertension: a real-world survey of physicians and patients in Latin America.

Pathway to care, treatment and disease burden of pulmonary arterial hypertension: a real-world survey of physicians and patients in Latin America.

Journal: BMJ open

Published: December 31, 2024

Inspiratory Muscle Training on Exercise Capacity, Dyspnoea and Health Status in Pulmonary Hypertension: A Randomised Controlled Trial.

Inspiratory Muscle Training on Exercise Capacity, Dyspnoea and Health Status in Pulmonary Hypertension: A Randomised Controlled Trial.

Journal: Respirology (Carlton, Vic.)

Published: October 12, 2024

Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR.

Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: August 23, 2024

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies.

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies.

Journal: The European respiratory journal

Published: July 22, 2024

Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.

Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.

Journal: The European respiratory journal

Published: June 29, 2023

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.

Journal: The New England journal of medicine

Published: March 06, 2023

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.

Journal: The European respiratory journal

Published: July 05, 2022

Risk assessment validation in patients with pulmonary arterial hypertension: Data from a Southern Brazil registry (RESPHIRAR study).

Risk assessment validation in patients with pulmonary arterial hypertension: Data from a Southern Brazil registry (RESPHIRAR study).

Journal: Pulmonary circulation

Published: April 25, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026